Professor David S. Jones FREng

RESEARCH FOCUS

Professor Jones' research seeks to provide materials science/engineering solutions to medical and pharmaceutical problems. 

These include patented innovations in the design of drug containing implants and medical devices to reduce the morbidity and mortality associated with medical device related infection.  Within the pharmaceutical domain, Professor Jones has developed novel, patented implants for the treatment of local diseases within the oral cavity, the vagina and the eye (anterior and posterior) and has developed and applied innovative engineering technologies to develop new drug delivery systems for oral administration. 

Find out more

RESEARCH OPPORTUNITIES

Professor Jones has opportunities for research within the following areas:

  • Novel bioactive biomaterials as implants
  • Implantable (mucoadhesive) drug delivery systems for application to the oral cavity, vagina and eye
  • Novel engineering strategies for improved medical device and dosage form performance
Make a PhD enquiry

 

Professor David S Jones

School of Pharmacy

Professor David Jones

A Chartered Engineer, Chartered Chemist, Chartered Statistician, a former Royal Society Industrial Fellow and a Fellow of the Royal Academy of Engineering with extensive experience in the commercialisation of pharmaceutical products and medical devices (>70 in total). 

 

PUBLIC OUTREACH and key achievements

I have extensive experience in the commercialisation of pharmaceutical products and medical devices (>70 in total).  Most recently I designed and developed an award-winning, commercially-available stoma sealant, (Cohesive Paste™), to prevent leakage and improve stoma health and patients’ quality of life (commercialised by TG Eakin).  In addition, in conjunction with Provita, I have commercialised a series of products designed for the enhanced treatments of infection in farmed animals.

I have been/am currently the founding member and Director of two award-winning, spin-out companies and am the author of several (12) patented technologies.

I am an elected Fellow of the following academies/institutions;

Research students

PhD Title: Novel bioactive implants for enhanced post-surgery recovery


Name: Abreu Passos
Years of Study: 2015-2019
Country: Angola

White Box 800 533

Alumni: where are they now?

Dr Michelle Bateson


PhD Title: Rheological Characterisation of Bioadhesive Drug Delivery Systems

Years of Study: 1997-2000

Country: United States of America

Current position: Vice-President, R&D, Analgesics and Respiratory Reckitt Benckiser (United Kingdom)

Dr. Brendan Muldoon


PhD Title: Mucoadhesive Systems for Drug Delivery

Years of Study: 1999-2002
Country: Northern Ireland
Current position: R&D Site Head, Teva Pharmaceuticals (United Kingdom)

Dr. Debby Caldwell


PhD Title: Characterisation of Drug Loaded Insoluble Polymeric Matrices Prepared By Hot Melt Extrusion Technology for Drug Delivery Applications

Years of Study: 2007-2011

Country: Northern Ireland

Current position: Drug Product Project Leader/ Formulation Project Leader, Novartis (Basle, Switzerland)

Dr. Hannah McMillan


PhD Title: Biodegradable sustained release systems for ocular drug delivery

Years of Study: 2011- 2014

Country: Northern Ireland

Current position: Formulation Scientist, Teva Pharmaceuticals (United Kingdom)

graduate school interior

Postgraduate Experience

The Graduate School

Our dedicated hub for postgraduate students, providing state-of-the-art facilities for study, and high-quality training and development programmes within a diverse interdisciplinary community.

The gateway to your postgraduate experience

Research at Queen's

Postgraduate research

Start your application

Apply now

Queen's University Belfast is committed to Equality, Diversity and Inclusion.
For more information please read our Equality and Diversity Policy.

Queen's University Belfast is registered with the Charity Commission for Northern Ireland NIC101788
VAT registration number: GB 254 7995 11